Sykehuset Ostfold Hf Kalnes

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Liver and biliary tract cancer1 trial
• Liver cirrhosis1 trial
• Melanoma1 trial
• Obesity1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• AstraZeneca1 trial
• Bristol-Myers Squibb Services Unlimited Company1 trial

Running trials

• Active, not recruiting

  Efficacy Study of Nivolumab Compared to Placebo in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIB/C Melanoma (CheckMate 76K)

  2022-502354-14-00· Phase 3· Bristol-Myers Squibb Services Unlimited Company· Source

Closed trials

• Completed

  A Study in Participants With Non-cirrhotic NASH With Fibrosis

  NCT05638737· Phase 2· AstraZeneca· Source